Dupilumab as a novel therapy for bullous pemphigoid

Int J Dermatol. 2023 Apr;62(4):e263-e266. doi: 10.1111/ijd.16525. Epub 2022 Nov 28.

Authors

Xuetong Zhang¹, Xiaoyong Man¹, Zhuangli Tang¹, Ru Dai¹, Ying Shen¹

Affiliation

¹ Department of Dermatology, The Second Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou, China.

PMID: 36440691
DOI: 10.1111/ijd.16525

No abstract available

Publication types

Letter

MeSH terms

Antibodies, Monoclonal, Humanized / therapeutic use
Humans
Pemphigoid, Bullous* / drug therapy

Substances

dupilumab
Antibodies, Monoclonal, Humanized